About Biopack:

Biopack manufactures 100% biodegradable consumer packaging products from locally available sugar cane waste called Bagasse. Based in Hong Kong with manufacturing facilities in Jiangmen, China, Biopack has earned the “premium brand” label in the biodegradable packaging market in Europe. Distributed under the “Roots Biopack” trademark, Biopack’s unique line of compostable packaging is sold in 12 European countries, North America, Hong Kong, Taiwan and South Africa. For investor inquiries and information about our comprehensive line of biodegradable packaging solutions, please visit our website at http://www.biopackenvironmental.com.

Safe Harbor

All statements other than statements of historical fact that are included in this press release and that mention activities, events or developments that we believe may occur in the future are forward-looking statements. The use of words such as “anticipate,” “continue,” “estimate,” “expect,” “may,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Forward-looking statements in this press release include Biopack’s belief there is strong potential for future growth in Eastern Canada and that Biopack and PLI have a solution for eastern growers and food services that the market has not seen before when it comes to quality, cost competitiveness and availability. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Risks that might cause actual results to differ from these projections include, but are not limited to, those discussed in Biopack’s most recent Annual Report on Form 10-KSB and other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry — physicians, pharmacists, medical institutions, consumers, access medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company’s website at www.medicaretech.com

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE’s products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE’s products and services, ability to deploy MDCE’s services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC’s assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC’s designees in order to close the acquisition. Accounting for the anticipated cancelation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of it common stock issued and outstanding upon the closing of the acquisition.

About Echo Therapeutics

Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo’s and its partners’ ongoing studies, including the efficacy of the Symphony tCGM System and Prelude SkinPrep System, the failure of future development and preliminary marketing efforts related to the Symphony tCGM System and Prelude SkinPrep System, Echo’s ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo’s ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM System and Prelude SkinPrep System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to the Symphony tCGM System and the Prelude SkinPrep System. These and other risks and uncertainties are identified and described in more detail in Echo’s filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2008, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

© 2002 – 2009 Echo Therapeutics, Inc. All rights reserved worldwide.

About Amico Games Corp.

Amico Games Corp. is a software company specializing in developing mobile phone games for the Chinese market. On December 31, 2009, Amico acquired Galaxy Software Limited is a Chinese private-owned company incorporated in November, 2001. Galaxy is one of the earliest mobile phone multiplayer game developers in China, as well as one of the first Chinese company to develop and operate Java(TM) MMRPOG (massive multiplayer role playing online games) mobile phone games. It is also the first company to provide multiplayer games over the WAP platform of China Mobile, the world’s largest mobile phone provider based upon subscribers. For more information, please visit the Amico’s website at: www.amicogames.com

Safe Harbor Statement:

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to Amico or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results, including revenue and customer projections, could differ materially from those contemplated by the forward-looking statements as a result of certain factors such as the level of business and consumer spending, the amount of sales of Amico’s products, the competitive environment within the industry, the ability of Amico to continue to expand its operations, the level of costs incurred in connection with Amico’s expansion efforts, economic conditions in the industry and the financial strength of Amico’s customers. Amico does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1151441

Contact Investor Relations Office Tel: 1-877-331-8777 Email: info@amicogames.com 201 Spear Street, Suite 1100 San Francisco, CA 94105 USA

About PlasmaTech, Inc.

PlasmaTech, Inc. is an innovator in the development, design, manufacturing and worldwide marketing of secure wireless solutions for consumer, industrial and government applications. PlasmaTech’s platform technology provides military-grade encryption security for the transmission of data, voice and video over wireless data communication links, offering extreme distances that were previously unachievable in the industry. Visit the Company’s website at www.plasmatechwireless.com.

Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in PlasmaTech’s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to the ability of PlasmaTech to pay its debts to RF Wireless in order to retain title to PlasmaTech’s intellectual property, the ability of PlasmaTech to effectively manage the intellectual property acquired from RF Wireless and integrate it into the business of PlasmaTech, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on PlasmaTech’s website does not constitute a part of this release.

NEW YORK, NY — (Marketwire) — 01/06/10 — Andes Gold Corporation. (PINKSHEETS: AGCZ) announced its corporate outlook for January, 2010.

Andes Gold Corporation is a gold producing and exploration company with operations in Ecuador, (South America). In the post market melt-down of 2008 the world took shelter in the security of gold pushing the value to over $1,100 USD per ounce by January, 2010. Producing gold properties such as Andes Gold will continue to enjoy increased prosperity which can only improve if the price continues to climb.

“The company is processing 50 tons of ore per day which consists of 8 grams of gold per ton and 15 grams of silver per ton daily average from the Carretera (Miranda vein) and Macas (Azul vein) shafts within the Miranda property. These tunnels have more sites ready from where the company can increase production with the plan to upgrade the processing plant,” stated Alex Diaz – President of Andes Gold. “In the short term, the company plans to increase production from the mine up to 80 tons of ore per day with the extraction start up of the Sorocha and Estralla veins (both untouched) in the Carretera tunnel,” further added Mr. Diaz.

About Andes Gold Corporation:

Andes Gold Corporation is a United States of America registered public company currently operating a gold mining and exploration corporation, through its wholly owned subsidiary company Compania Minera PLS.A. In Ecuador, (South America) which controls a Gold mining and exploration concession called the Miranda Alto. For more information please visit: www.andesgold-ir.com

Important Information:

About Forward-Looking Statements: Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company’s website does not constitute a part of this release.

NT Media Corp. (www.ntmedia.tv) (OTCBB: NTMI), a developer and operator of media and social networking websites, announced today that the company has secured actress and Deal Or No Deal briefcase model, Leyla Milani, for its upcoming exclusive original comedy series produced for the alternative-format video-sharing site NeuroTrash.tv.

Scheduled for release in early 2010, the webisode series is currently in pre-production and features nightlife anecdotes with an ensemble cast, produced by NT Media as part of an ongoing initiative to deliver original content to its website properties.

Launched in January 2009, NeuroTrash.tv is a video-sharing site targeting young adults between the ages of 18 and 35. Users are able to post and share videos on the site, as well as take advantage of the site’s video player for sharing original videos on their own sites, social networking profile pages and blogs.

“We are proud to have signed Leyla Milani for the NeuroTrash.tv webisode series,” said NT Media CEO Ali Moussavi. “A rising star in television from WWE and Deal Or No Deal to appearances on NBC and MTV, Leyla’s talents for the screen have been invaluable to the production and we look forward to seeing her work go live on the NeuroTrash.tv website.”

For advertising and sponsorship opportunities, please email contact@ntmedia.tv.

NT Media’s revenue model for NeuroTrash.tv is based on standard display banner ads, in-stream video advertising, products sales and services. Advertisers are also able to earn revenue from video ads embedded in other websites on which NeuroTrash.tv users place videos.

About NT Media

NT Media is a start-up digital media solutions provider and developer of niche content websites. The interactive and community-oriented content for NT Media sites, as well the sites’ advertising, target specific interest groups and demographics in order to create an ongoing and open dialogue on trending topics and issues. NT Media’s online communities integrate increasing trends in online social networking and community building, user generated original content and third-party applications.

Forward-Looking Statements

Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, performance, or achievement expressed or implied by such forward-looking statements to differ.

STEVENSON, Wash., Oct 29, 2009 (BUSINESS WIRE) –Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that it has received approval for importation of ImmuSANO(TM) and GlucoSANO(TM) from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles. Caribbean International Medical N.V. (”CIM”), based in Curacao, is the exclusive distributor for The Netherlands Antilles, Aruba, Trinadad-Tabago and Suriname with the option to expand to other Caribbean islands based on certain commercial benchmarks. The initial 1,000 unit shipment to CIM was sent on Thursday October 29th.

“CIM is an experienced sales and marketing company throughout the Caribbean,” stated Marvin S. Hausman MD, CEO. “We are very happy to have CIM as a partner to handle the marketing, sales and distribution of our products in this geographic area.”

“I am very excited that our company has partnered with TNS and we will utilize all of our expertise to commercialize the unique TNS product line throughout the Caribbean,” stated Lloyd Philbert, CEO of CIM.

About Total Nutraceutical Solutions, Inc.:

Total Nutraceutical Solutions, Inc. (TNS), is an emerging nutraceutical company with a focus on discovering, formulating and marketing products composed primarily of organic natural mushroom compounds that contain bioactive nutrients for potential health benefits. TNS develops production and analytic technologies for food and nutritional supplements composed primarily of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to preventative healthcare formulations and nutritional approaches to a wide variety of human conditions and illnesses, TNS also develops and acquires breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the transaction described in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2008, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

SOURCE: Total Nutraceutical Solutions, Inc.

For Total Nutraceutical Solutions, Inc. Roberta Matta, 509-427-5132 www.totalnutraceutical.com

SAN DIEGO, CA–(Marketwire – October 30, 2009) – San West, Inc. (OTCBB: SNWT), a Company that designs, manufacturers, sells and repairs off-road vehicles, apparel and accessories, issues update regarding upcoming 5 for 1 forward stock split.

“Due to a delay caused by communication problems between FINRA and a third party in satisfying all regulatory requirements with respect to our proposed five for one forward split which was scheduled to occur on November 2, San West has decided to postpone the effective date of the proposed split until all regulatory requirements have been met. San West notified FINRA of its intent with respect to the proposed forward split on October 9, but was not notified by FINRA of a problem until the afternoon of October 27. As soon as San West became aware of the problem, it took immediate steps to provide all needed information. San West will notify its shareholders of the ‘ex-date’ of the forward split as soon as possible. The ‘ex-date’ is defined as the day before which an investor must have purchased the company’s stock in order to receive the additional shares. If you purchase a stock on the ‘ex-date’ for a split or distribution you are not entitled to the split stock or that distribution. However, the opening price for the stock will have been reduced by an appropriate amount, as on the ex-dividend date. Weekly financial publications, such as Barron’s, often include a stock’s upcoming ‘ex-date’ as part of their stock tables. San West will notify its shareholders of the effective date of the forward split as soon as possible.”

The company hopes to have all matters cleared by FINRA early next week.

About San West, Inc.

San West designs, manufacturers, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies. Products are sold via three divisions: at retail store locations, via the online store and through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee, California retail location.

For further information about San West, Inc. visit www.CountyImports.com, www.BuggyWorld.net and www.SanWestInc.com.

Certain statements contained herein are “forward-looking” statements (as defined — Private Securities Litigation Reform Act of 1995). SNWT cautions that the statements made in this press release constitute forward-looking statements and no guarantees of future performance and actual results or developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at time the statements are made.

HUDSON, Colo., Oct. 30 /PRNewswire-FirstCall/ — Magnum D’Or Resources, Inc. (OTC Bulletin Board: MDOR), a next generation rubber solutions company, announces a Legislative and Media Event at the Magnum Recycling USA Hudson, Colorado site (HERE). Magnum will be showcasing its recently acquired and renovated tire landfill site to the public.

On November 2nd, Magnum Recycling USA is extending an invitation to State Legislators, Dignitaries, and the Media to introduce the newly renovated Hudson Tire Facility. Magnum is proud of the fact that since acquiring the site that is has been completely cleaned, renovated, and brought into compliance with all State and County regulations. For more information or if you would like to attend the press event, please contact Magnum Recycling USA at (303) 536-4581.

Bryan Brammer, COO of Magnum Recycling USA, stated, “We are thrilled to showcase the site to several of our State and Local Representatives showing them what we have already accomplished in such a short period of time. This is only the first step in what is to become a World renowned Rubber Solutions Facility.”

Magnum looks forward to updating the market on its operational and licensing permits for the Hudson, Colorado site next week. We feel there are some electrifying times ahead of us for our shareholders.

About MDOR: Magnum’s proprietary “Green” technology provides a one-of-a-kind solution to all of the challenges in eliminating stockpiles of scrap tires and rubber scrap. Magnum’s positioned itself to become a global leader in rubber and scrap tire recycling and its Next Generation technology could potentially revolutionize the industry Worldwide.

Photo gallery: http://magnumresources.net/gallery/?level=collection&id=1

Magnum Recycling Canada: Magnum’s Magog, Quebec facility is 98,000+ sq. ft. Magnum is currently producing rubber buffing, nuggets, and crumb from recycled scrap tires. Company holds over $130 Million USD in open contracts.

Magnum Recycling USA: Magnum’s Hudson, Colorado facility consists of 120 acres of high grade commercially zoned land, buildings, equipment, and inventory in excess of 30,000,000+ tires. The facility is one of the largest tire landfills in the world.

Magnum Engineering International (http://magnumei.com/): wholly owned subsidiary of Magnum specializing in developing turnkey recycling plants and complete environmental & economical ‘Green’ solutions.

Magnum/SRI are currently using their Revolutionary technologies to produce next generation rubber recycling solutions for custom compounds, retread compounds, processing aids, advanced state-of-the-art equipment, and reactivated ambient/cryogenic rubber powders for the global market. Magnum/SRI premium compounds can be substituted in high specification compound applications without appreciable loss in properties or performance. The reason why our clients (market) will prefer to use Magnum/SRI compounds is because they will be able to enjoy a substantial and meaningful reduction in raw material cost without compromising product performance and quality. To visit SRI: http://www.srielastomers.com

Magnum/SRI Independent Test Results from Rubber Research Institute of Malaysia Mark Historic Event for the Global Rubber Industry: http://magnumresources.net/investors/565, http://magnumresources.net/news/607

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements contained in this document that are not historical fact are forward-looking statements based upon management’s current expectations that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. The results anticipated by any or all of these forward-looking statements may not occur. The company is not required to update its forward-looking statements.